SUPER-REFRACTORY STATUS EPILEPTICUS
Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.
Never miss a new study
Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear
Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for stopping Life-Threatening seizures
Disease control CompletedThis study tested a drug called SAGE-547 in 132 people with super-refractory status epilepticus, a dangerous condition where seizures don't stop with standard treatments. The drug was given as a continuous IV infusion to see if it could help patients come off strong sedatives and…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug shows promise for stopping deadly seizures
Disease control CompletedThis study tested a drug called SAGE-547 in 25 people with super-refractory status epilepticus, a condition where seizures continue despite standard treatments. The goal was to see if the drug is safe and tolerable. Participants received the drug by IV infusion, and researchers m…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE1, PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:02 UTC